{"id":"NCT03729362","sponsor":"Amicus Therapeutics","briefTitle":"A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease","officialTitle":"A Phase 3 Double-blind Randomized Study to Assess the Efficacy and Safety of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease Compared With Alglucosidase Alfa/Placebo","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-04","primaryCompletion":"2020-12-15","completion":"2021-01-15","firstPosted":"2018-11-02","resultsPosted":"2023-09-11","lastUpdate":"2025-09-11"},"enrollment":125,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pompe Disease (Late-onset)"],"interventions":[{"type":"BIOLOGICAL","name":"Cipaglucosidase Alfa","otherNames":["ATB200"]},{"type":"DRUG","name":"Miglustat","otherNames":["AT2221"]},{"type":"BIOLOGICAL","name":"Alglucosidase Alfa","otherNames":["Myozyme"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Cipaglucosidase Alfa/Miglustat","type":"EXPERIMENTAL"},{"label":"Alglucosidase Alfa/Placebo","type":"ACTIVE_COMPARATOR"}],"summary":"This is a phase 3 double-blind randomized study to study the efficacy and safety of intravenous ATB200 Co-administered with oral AT2221 in adult subjects with Late Onset Pompe Disease compared with Alglucosidase Alfa/placebo.","primaryOutcome":{"measure":"Change From Baseline to Week 52 in 6 Minute Walk Distance (6MWD)","timeFrame":"Baseline, Week 52","effectByArm":[{"arm":"Cipaglucosidase Alfa/Miglustat","deltaMin":21.31,"sd":11.56},{"arm":"Alglucosidase Alfa/Placebo","deltaMin":7.1,"sd":7.043}],"pValues":[{"comp":"OG000 vs OG001","p":"0.048"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":73,"countries":["United States","Argentina","Australia","Austria","Belgium","Bosnia and Herzegovina","Bulgaria","Canada","Denmark","France","Germany","Greece","Hungary","Italy","Japan","Netherlands","New Zealand","Poland","Slovenia","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["40342075","39535661","39318718","38294575","34800400"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":85},"commonTop":["Fall","Headache","Nasopharyngitis","Myalgia","Nausea"]}}